A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer

File Size Format
62502_1.pdf 303Kb Adobe PDF View
Title A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer
Author Newton, Robert U; Taaffe, Dennis R; Spry, Nigel; Gardiner, Robert A; Levine, Gregory; Wall, Bradley; Joseph, David; Chambers, Suzanne Kathleen; Galvão, Daniel A
Journal Name BMC Cancer
Year Published 2009
Place of publication United Kingdom
Publisher BioMed Central Ltd.
Abstract Background Androgen deprivation therapy (ADT) is accompanied by a number of adverse side effects including reduced bone mass and increased risk for fracture, reduced lean mass and muscle strength, mood disturbance and increased fat mass compromising physical functioning, independence, and quality of life. The purpose of this investigation is to examine the effects of long term exercise on reversing musculoskeletal-related side effects, and cardiovascular and diabetes risk factors in men receiving androgen deprivation for their prostate cancer. Specifically, we aim to investigate the effects of a 12-month exercise program designed to load the musculoskeletal system and reduce cardiovascular and diabetes disease progression on the following primary endpoints: 1) bone mineral density; 2) cardiorespiratory function and maximal oxygen capacity; 3) body composition (lean mass and fat mass); 4) blood pressure and cardiovascular function; 5) lipids and glycemic control; and 6) quality of life and psychological distress. Methods/Design Multi-site randomized controlled trial of 195 men (65 subjects per arm) undergoing treatment for prostate cancer involving ADT in the cities of Perth and Brisbane in Australia. Participants will be randomized to (1) resistance/impact loading exercise, (2) resistance/cardiovascular exercise groups and (3) usual care/delayed exercise. Participants will then undergo progressive training for 12 months. Measurements for primary and secondary endpoints will take place at baseline, 6 and 12 months (end of the intervention). Discussion The principal outcome of this project will be the determination of the strength of effect of exercise on the well established musculoskeletal, cardiovascular and insulin metabolism side effects of androgen deprivation in prostate cancer patients. As this project is much longer term than previous investigations in the area of exercise and cancer, we will gain knowledge as to the continuing effects of exercise in this patient population specifically targeting bone density, cardiovascular function, lean and fat mass, physical function and falls risk as primary study endpoints. In terms of advancement of prostate cancer care, we expect dissemination of the knowledge gained from this project to reduce fracture risk, improve physical and functional ability, quality of life and ultimately survival rate in this population.
Peer Reviewed Yes
Published Yes
Alternative URI http://dx.doi.org/10.1186/1471-2407-9-210
Copyright Statement Copyright 2009 Newton et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Volume 9
Page from 1
Page to 8
ISSN 1471-2407
Date Accessioned 2010-04-24
Date Available 2012-02-10T02:38:29Z
Language en_US
Comments Page numbers are not for citation purposes. Instead, this article has the unique article number of 9:210.
Research Centre Centre for Health Practice Innovation; Behavioural Basis of Health
Faculty Griffith Health Faculty
Subject Exercise Physiology
URI http://hdl.handle.net/10072/29881
Publication Type Journal Articles (Refereed Article)
Publication Type Code c1

Show simple item record

Griffith University copyright notice